title: Editorial: Promising approaches to identify DILI drugs.
authors.affiliation: In Vitro ADMET Laboratories Inc., Columbia, MD, USA. Electronic address: liabert@invitroadmet.com.
authors.forename: Albert P
authors.initials: AP
authors.lastname: Li
authors.affiliation: The National Center for Toxicological Research U. S. Food and Drug Administration, Jefferson, AR, USA. Electronic address: Jie.Zhang@fda.hhs.gov.
authors.forename: Jie
authors.initials: J
authors.lastname: Zhang
mesh_terms: D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism; D018675:Toxicity Tests / Q000379:methods
chemical_list: D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System